APOE and atherosclerosis: The effect of UAMC-3203 (12.35 mg/kg/day) on atherosclerosis was evaluated in ApoE−/−Fbn1C1039G+/− mice fed a western-type diet (WD) for 12 weeks (n = 13 mice/group) or 20 weeks (n = 16–21 mice/group) to distinguish between plaques without and with established IP angiogenesis, respectively.